AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2022
Feb 18, 2022
35221_dirs_2022-02-18_f93090af-b3c9-4d00-adac-936c01e7f33e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2022-02-11
Reporting Person: Harvey Joan B (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-11 | Employee stock option (right to buy) | $2.05 | A | 179350 | Acquired | 2032-02-11 | Common stock (179350) | Direct |
Footnotes
F1: The option vests in 12 quarterly installments, commencing March 31, 2022.
More from PAVmed Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Jan 23